Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
A shot of a chameleon using its tongue to grab dinner has snatched a top photography award.
One story dominates Thursday's front pages with some newspapers printing emotive pleas to voters to keep the United Kingdom as one.
After a mild start temperatures should pick up, with the south of England seeing highs of 26C.